Ann: US Roadshow - Investor Presentation, page-5

The best ideas and investments need little explanation as to their novelty and value. That presentation only has about 10 pages of concise information, but is easily more exciting that any recent startup I've seen. Such a short runway to commercialisation, such low barriers to widespread roll-out, I would be amazed if advanced discussions with US telehealth providers haven't already occurred. This could easily run to a market cap in excess of $100 million in the very short term, if it doesn't and the clinical trials continue to look so promising (particularly the Australian adult trial) it will get taken over IMO. Hold on to your hats, lots of volatility in the short term but very excited to see where we get to in the next six months...